Immupharma took the stairs #bearishIMM matches the adage, "Markets take the stairs up and the elevator down".
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.92 M GBP
0.00 GBP
366.76 M
About IMMUPHARMA PLC
Sector
CEO
Timothy Paul McCarthy
Headquarters
London
Website
Founded
2000
ISIN
GB0033711010
FIGI
BBG000C01SG5
ImmuPharma Plc engages in the research, development, and commercialization of pharmaceutical products. It is focused on the development of drugs, primarily based on peptide therapeutics, to treat serious medical conditions such as autoimmune diseases. The firm's portfolio consists of four novel peptide therapy areas: autoimmunity, metabolism, cancer and anti-infectives. Its drug Lupuzor, is a potential treatment for the autoimmune chronic inflammatory disease lupus. The company was founded by Richard Warr and Dimitri F. Dimitriou in 1999 and is headquartered in London, the United Kingdom.
Immupharma - Risen from the dead or dad cat bounce?All signs look to a dead cat bounce. Obviosuly everyone knows this has been trending down for almost 2 years.
This has no consolidation under the 32p resistance, a weekly close under the previous 19p support is not a good look.
Very good news was fomo'd into. Next news should be a while, thi
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of IMM is 1.570 GBX — it has decreased by −1.26% in the past 24 hours. Watch IMMUPHARMA ORD GBP0.01 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange IMMUPHARMA ORD GBP0.01 stocks are traded under the ticker IMM.
IMM stock has fallen by −12.53% compared to the previous week, the month change is a −18.55% fall, over the last year IMMUPHARMA ORD GBP0.01 has showed a −4.85% decrease.
IMM stock is 8.21% volatile and has beta coefficient of 0.10. Track IMMUPHARMA ORD GBP0.01 stock price on the chart and check out the list of the most volatile stocks — is IMMUPHARMA ORD GBP0.01 there?
Today IMMUPHARMA ORD GBP0.01 has the market capitalization of 6.62 M, it has decreased by −4.22% over the last week.
Yes, you can track IMMUPHARMA ORD GBP0.01 financials in yearly and quarterly reports right on TradingView.
IMMUPHARMA ORD GBP0.01 is going to release the next earnings report on May 22, 2025. Keep track of upcoming events with our Earnings Calendar.
IMM net income for the last half-year is −387.85 K GBP, while the previous report showed −847.37 K GBP of net income which accounts for 54.23% change. Track more IMMUPHARMA ORD GBP0.01 financial stats to get the full picture.
No, IMM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, IMM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMMUPHARMA ORD GBP0.01 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IMMUPHARMA ORD GBP0.01 technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IMMUPHARMA ORD GBP0.01 stock shows the sell signal. See more of IMMUPHARMA ORD GBP0.01 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.